Rick Simpson Oil (RSO) in Haralson County, Georgia: The Complete Guide by OilWell Cannabis

If you’re reading this in Haralson County — whether you’re in Buchanan, Bremen, Tallapoosa, or out in the rural stretches between them — you’re likely here because you’re looking for honest answers about cannabis oil. Maybe you’re a veteran dealing with PTSD after serving our country. Maybe you’ve spent decades in manufacturing or agriculture around here and your body is telling you the work’s been hard. Maybe someone you love is facing a cancer diagnosis, and you’re searching for options beyond what you’ve heard at Tanner Health in Carrollton or WellStar in Atlanta. Maybe you’re just tired of pills that don’t work and side effects that make life harder.

We get it. We really do. And we want you to know something upfront: this isn’t about getting high. This is about getting honest, science-based information that helps you make informed decisions about your health. That’s why we’re laying everything out — the history, the science, the legal framework, our exact formulas, and how they might apply to life in northwest Georgia.

ABOUT RICK SIMPSON AND TRADITIONAL RICK SIMPSON OIL

Who is Rick Simpson

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical professional — he was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him. That story resonates in Haralson County, where many of us have learned the hard way that the medical system doesn’t always have answers — especially for chronic pain, sleep issues, or the kind of deep-seated anxiety that comes from trauma or years of hard physical work.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. According to Simpson, the medications he was prescribed either failed to help or made his condition worse. He reported that cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe cannabis, the request was refused .

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, in which THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became a foundational reference point in Simpson’s later advocacy, even though its findings were never replicated in controlled human cancer trials .

The pivotal moment in Simpson’s story came in 2003. He reported that three bumps on his arm were diagnosed by his doctor as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification of this outcome has been published, and no biopsy confirmation or clinical follow-up has been documented in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil and the foundation of everything that followed .

Important context: Simpson’s account is presented here as his personal testimony. The absence of clinical documentation, controlled observation, or independent medical confirmation means these events cannot be evaluated as medical evidence. They are, however, historically significant as the catalyst for a global movement around concentrated cannabis oil. We share this story because it’s the honest origin of RSO, not because we’re making medical claims.

The crusade — spreading the oil

After his 2003 experience, Simpson committed himself fully to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others in his community. He helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia . In Haralson County, where community support runs deep and people look out for each other, this approach resonates — even if we can’t legally replicate his free-distribution model today.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure. Within cannabis communities, it was foundational — for many people, Run From The Cure was their introduction to the concept of concentrated cannabis oil as medicine .

What is traditional Rick Simpson Oil — the product

Traditional RSO refers to the specific type of concentrated cannabis oil Simpson made. It was defined not by lab specifications but by his method and materials.

Source material: Simpson used high-THC, indica-dominant cannabis strains. There was no strain standardization — the starting material varied by availability and growing season.

Extraction solvent: Simpson originally used naphtha — a petroleum-based solvent — later also endorsing 99% isopropyl alcohol. Neither is a food-grade solvent, which is a significant safety issue.

Extraction process: The solvent was used to dissolve cannabinoids from plant material, then evaporated in a rice cooker. The process was crude, with no temperature control, no testing, and no standardization.

Appearance: Traditional RSO was an extremely dark — nearly black — thick, viscous, tar-like oil with a strong cannabis odor and possible solvent-residual smell.

Cannabinoid profile: Primarily decarboxylated delta-9 THC at 60-90% concentration, with naturally occurring minor cannabinoids at uncontrolled ratios. No lab verification.

Terpene content: Minimal to none. The high-heat process destroyed terpenes.

Standardization and testing: None. Every batch was different.

Residual solvent risk: This is one of the most significant safety concerns. Naphtha may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging leaves harmful residues.

Simpson’s claims vs. the evidence record

Rick Simpson stated that RSO could cure cancer and many other diseases. He was adamant and consistent about these claims throughout his advocacy career .

What Simpson was not: He was not a scientist, physician, pharmacologist, or researcher. He had no formal medical training, never conducted a clinical trial, and never submitted his results to peer review. His entire evidence base consisted of personal experience and testimonials gathered informally.

What the preclinical literature shows: In vitro studies have demonstrated that THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal model studies have shown some tumor-growth inhibition . These findings are scientifically interesting but have not translated into proven human cancer cures.

What the preclinical literature does not show: No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer. The gap between in vitro/animal results and human outcomes is vast.

Institutional positions: The U.S. National Cancer Institute (NCI) acknowledges cannabinoid anticancer research but does not endorse cannabis as a cancer treatment . The FDA has not approved any cannabis plant product for cancer. Health Canada has never approved RSO for cancer .

What Simpson got right: He drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. He helped create the conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: His cure claims exceeded the evidence. Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential. Delayed or foregone treatment is a documented concern.

Traditional RSO vs. modern formulated RSO

For our friends in Haralson County who may have heard about RSO through word-of-mouth or online research, here’s what makes modern formulations different:

Dimension	Traditional RSO	OilWell formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets (553 mg/mL)
Lab testing	Not available or performed	Full panel testing for potency, terpenes, pesticides, heavy metals, residual solvents, microbial contaminants
Residual solvents	Significant risk with naphtha	Controlled and tested
Dosing precision	Approximate, syringe-based	Measured per mL with known cannabinoid content
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No — fully decarboxylated by heat	Yes — THCa included as a separate ingredient at 1,500 mg
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted
Legal status	Illegal Schedule I substance	Farm Bill compliant, hemp-derived, ships legally to Georgia

ABOUT OILWELL CANNABIS AND THE OILWELL RSO FORMULA

The origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas — right across the river from Reynosa, Mexico, in one of the most economically challenged and dangerous border regions. He learned early on what it means to hustle and survive when the odds are stacked against you. By sixteen, he’d seen enough violence and loss to last a lifetime and had to leave home for good.

Despite the dangers, Colin didn’t fall into selling harder substances. He focused on cannabis, seeing it as a safer alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately. Later, he became a formally trained software engineer and did custom development work for Baylor College of Medicine — one of the most prestigious medical institutions in the Texas Medical Center. That combination — deep cannabis plant knowledge plus medical-grade technical precision — defines OilWell’s approach today.

Here in Haralson County, we know what it means to work hard and face challenges. Many of us have worked in manufacturing, agriculture, or small businesses that built this community. We understand what it’s like when conventional solutions fail and you have to find another way. That’s exactly what happened with Bentley.

Bentley was Colin’s dog — family, not just a pet. When Bentley fell seriously ill, vets said euthanasia was the only humane option. He was paralyzed in his back legs, and pain medications would destroy his internal organs. But giving up wasn’t an option. A rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

That question changed everything. Colin created CBD golden paste for Bentley. And Bentley got up — from paralyzed and facing euthanasia to walking over and bringing Colin his ball to play. Dogs don’t respond to placebo. This was real.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced: neurodegeneration, dementia, glaucoma, crippling arthritis. Single cannabinoids weren’t enough. Multi-cannabinoid synergy became essential. Precision mattered because Bentley’s life depended on it.

That same multi-cannabinoid approach is what we bring to Haralson County residents today. Whether you’re dealing with chronic pain from years of physical work, PTSD from military service, sleep issues that pills can’t fix, or the anxiety that comes with life’s pressures, our formulas reflect a decade of real-world testing on a patient who couldn’t speak for himself but whose health depended on getting it right.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. He quit Xanax cold turkey using the cannabinoid knowledge he developed with Bentley. The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD to this day. This isn’t theoretical knowledge — it’s lived experience.

Over time, doctors began using our formulas for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. We’ve developed products for vegans, diabetics, and those with specific health needs because we believe accessibility means serving everyone.

ABC13 KTRK Houston — Houston’s number-one news source — featured Colin and OilWell Cannabis in seven comprehensive news segments from 2019 to 2023. In 2019, Colin told ABC13: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

That quote captures everything we stand for. We’re not here to hype. We’re here to give you the best possible information so you can decide for yourself.

Today, OilWell Cannabis operates from Montrose, Houston, Texas — but we serve customers nationwide, including right here in Haralson County. We’ve been operating since 2019, maintain a near-5.0 Google rating, and are Texas DSHS licensed. All our artwork, formulations, and packaging are created in-house in Houston. We bring Houston grit and McAllen roots to everything we do, but our posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

The OilWell RSO philosophy

OilWell’s RSO is not traditional Rick Simpson Oil. It’s a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in deliberate, evidence-motivated ways designed to solve the problems that limited Rick Simpson’s original vision.

Four core principles define our approach:

1. Accessibility over gatekeeping. No medical card is required. Anyone age twenty-one or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality. Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally — even here in Georgia where medical cannabis access is extremely limited.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their own medicine; we engineered a product that puts that control in your hands through chemistry rather than rhetoric.

3. Open-source formulas. We publish our complete formulas publicly — every cannabinoid, every milligram amount, every percentage — so that anyone who cannot afford our products can source ingredients and make their own version. Simpson gave his oil away for free and taught people how to make it; we adapted that ethos for the modern cannabinoid marketplace by selling a professionally manufactured product and publishing the recipe.

4. Evidence-informed, not evidence-overstating. The research citations throughout this document represent our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

Farm Bill compliance and the THCa legal framework

For Haralson County residents, this is critical information. The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our legal framework.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle — 3 milligrams per milliliter — well under the 0.3% threshold. All cannabinoids in our formula are hemp-derived. The product is legal under federal law and in Georgia.

THCa — tetrahydrocannabinolic acid — is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC.

Here’s what matters for you in Haralson County: You can legally purchase, possess, and transport our product. You can then decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45 to 60 minutes in an oven-safe glass container. This converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams of delta-9 THC in the formula, this produces approximately 1,405 milligrams of total delta-9 THC — giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

This means the same product can function as a non-psychoactive anti-inflammatory (used raw) or as a full-potency psychoactive cannabinoid product (after home decarboxylation). You control the decision. The product is legal everywhere all component cannabinoids are legal, which enables us to ship to Haralson County and throughout Georgia.

Important legal notice: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with Georgia laws regarding cannabinoid products. We ship with full documentation, Certificates of Analysis (COAs), and receipts. International customers accept all customs and legal responsibility.

Open-source formulas — why OilWell publishes everything

We publish our complete RSO formulas publicly — every cannabinoid, every milligram amount, every percentage. The RSO Sublingual Oil formula and RSO Vape Cartridge formula are detailed later in this document.

If someone in Haralson County cannot afford our products — $129.99 for the sublingual oil, $49.99 for the vape cartridge — they can see exactly what the formula contains, source the individual cannabinoid distillates and isolates, and make their own version. The formulas are the open-source formulas.

This is a direct echo of Rick Simpson’s original ethos. He gave his oil away for free and taught people how to make it. He never patented his method. We adapted that ethos for the modern cannabinoid marketplace: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

As Colin Valencia said on ABC13 in 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

The open-source philosophy started with Bentley. Here is the actual CBD golden paste recipe that saved Bentley’s life, so that any pet owner in Haralson County facing a similar crisis can make it themselves:

CBD golden paste recipe for pets — the original open-source formula

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on the size and needs of the pet; consult with a veterinarian)

Instructions:

1. Mix the turmeric and water in a saucepan over low heat, stirring continuously until it forms a thick paste (about 7 to 10 minutes). Add a little more water if it becomes too thick.
2. Add the coconut oil and freshly ground black pepper. Stir until all ingredients are thoroughly mixed.
3. Allow the paste to cool, then transfer it to a jar with a lid. Store it in the refrigerator for up to two weeks.
4. Add a small amount of CBD oil to the paste before giving it to the pet, adjusting the dosage based on their weight and health needs. Start with a low dose and gradually increase as needed.

Serving suggestion: Mix a small amount of the golden paste with the pet’s food once or twice a day. Monitor the pet for any changes and consult with a veterinarian if there are any concerns. Always consult with a veterinarian before starting any new supplement regimen for a pet.

This recipe — published for free, years before the RSO formulas were open-sourced — demonstrates that the pattern is consistent. Colin gave away the formula that saved Bentley before he gave away the formula designed for people. The open-source ethos is not a marketing strategy. It is the foundational behavior of our company.

The decarboxylation choice — patient-controlled potency

Traditional RSO was always fully decarboxylated. The heat of solvent evaporation converted all THCa into delta-9 THC, leaving patients with no choice about psychoactivity.

Our sublingual formula contains 1,500 milligrams of THCa in its acidic, non-psychoactive form. This creates three distinct usage options for you:

Option 1 — Raw, no heat. All 1,500 milligrams stays as THCa — completely non-psychoactive. The THCa evidence profile describes potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This option is compatible with work, driving through Haralson County, and daytime use with zero psychoactive impairment.

Option 2 — Fully activated, home decarboxylation. Heating the oil at 260°F (125°C) for 45 to 60 minutes in an oven-safe glass container converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams of delta-9 THC already in the formula, this yields approximately 1,405 milligrams of total delta-9 THC. Combined with 6,000 milligrams of delta-8 THC, the activated product achieves psychoactive potency comparable to traditional high-THC RSO — 100% legally, because decarboxylation occurs at your discretion after purchase. You may also transfer a controlled portion of the oil from the original bottle into a second empty oven-safe glass container, decarboxylating only what you intend to use and preserving the remainder in its raw THCa form.

Option 3 — Vape, auto-decarboxylation. The RSO Vape Cartridge vaporizes at 400 to 450°F, which instantly converts THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids. This is the fastest-onset RSO delivery method available.

The conversion chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 milligram THCa = 0.877 milligrams delta-9 THC after decarboxylation, reflecting the loss of a CO₂ molecule during the reaction.

This design puts the potency decision entirely in your hands — aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing that principle through actual product chemistry.

Solvent-free production

Our RSO is not an extraction product in the traditional sense. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents are present in the finished product.

This approach eliminates the residual solvent risk that is one of the most significant safety concerns with traditional RSO production.

The product uses organic MCT oil (medium-chain triglycerides) as the carrier base. MCT oil is a food-grade lipid carrier that facilitates cannabinoid absorption through sublingual tissue and provides a neutral taste profile — a significant improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-party lab testing covers cannabinoid potency, terpene profile, and safety panels including pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and accessible through our website.

Two product formats

We offer the RSO formula in two delivery formats, each designed for different use cases.

RSO Sublingual Oil — $129.99

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg per mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper for precise dosing in 0.1 mL increments
• Onset: 15 to 45 minutes
• Peak effects: 1 to 2 hours
• Duration: 4 to 6 hours
• Bioavailability: 13 to 19%
• Approximately 40 to 60 doses per bottle depending on serving size

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900 mg+ total cannabinoids
• Same six-cannabinoid ratio as sublingual formula
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1 to 2 minutes
• Peak effects: 10 to 15 minutes
• Duration: 2 to 4 hours
• Bioavailability: 10 to 35%
• Automatic THCa decarboxylation at vaping temperature (400 to 450°F)

When to use each format

Use case	Recommended format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability and discretion	Vape	Compact, no measuring required
Precise dosing control	Sublingual	Graduated dropper in 0.1 mL increments
Daytime non-psychoactive use	Sublingual (raw)	THCa stays inactive, zero impairment
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC

Condition-specific usage context for Haralson County residents

Important disclaimer: The following usage contexts are informed by cannabinoid research and our formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-related nausea and appetite support

• Pre-chemo: 0.5 to 1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2 to 3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0 to 2.0 mL sublingual before bed (delivers 25 to 50 mg CBN)
• Evidence context: delta-8 THC antiemetic evidence [9], delta-9 THC nausea evidence [1][13], CBD buffering effects [3]

Chronic pain (fibromyalgia, arthritis, neuropathy, work-related injuries)

For those of you in Haralson County who’ve spent years in manufacturing at the local plants, working on farms, or in construction around the West Georgia area, chronic pain is a daily reality. Our approach:

• Daytime: 0.3 to 0.5 mL raw sublingual — provides anti-inflammatory cannabinoid exposure without psychoactive impairment, so you can work, drive, and function
• Nighttime: 0.5 to 1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep support

• Before bed: 1.0 to 2.0 mL sublingual
• At 2.0 mL, this delivers 50 mg CBN — the dosage level investigated in the 2024 sleep literature
• At 1.0 mL, this delivers 25 mg CBN — above the 20 mg threshold associated with reduced sleep disturbance
• Evidence context: CBN sleep evidence [16][17]

Anxiety and stress

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety-related pathways without psychoactive impairment
• Nighttime: 1.0 mL sublingual — full cannabinoid profile including CBN for sleep architecture
• Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

General titration principle: Start low, go slow. Begin with 0.25 to 0.5 mL sublingual and assess effects over 2 to 3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery and global accessibility to Haralson County

We operate the only same-day RSO delivery system in Houston, but for Haralson County residents, we offer nationwide shipping that delivers directly to your door anywhere in Georgia.

Nationwide shipping to Haralson County

• All 50 states where Farm Bill-compliant products are legal (including Georgia)
• USPS Priority Mail (2 to 3 business days), FedEx and UPS Ground (3 to 5 business days)
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for Georgia’s hot summers
• Signature-required option available

International shipping
We ship internationally and have delivered to multiple countries across multiple continents. The THCa legal framework makes this possible: because the product contains less than 0.3% delta-9 THC at the point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill.

• All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs purposes
• Minimum flat-fee shipping applies; excessive international shipping costs are billed to the customer
• The customer is responsible for verifying legality in their jurisdiction and accepts all customs and legal risk
• Contact: (832) 416-2816 or [email protected]

The significance of this access for Haralson County cannot be overstated. Rick Simpson could not ship his oil anywhere — it was Schedule I, illegal to produce, possess, or transport. Today, a cancer patient in Buchanan, a veteran in Bremen dealing with PTSD, or a farmer in Tallapoosa with chronic pain can legally access the same clinical-strength multi-cannabinoid RSO formula that a Houston resident receives. We built a product that can move across state lines legally — completing a piece of Rick Simpson’s vision that prohibition made impossible.

How the OilWell formulas connect to the evidence

Every cannabinoid in our formula — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — has its own evidence profile in the GENERAL KNOWLEDGE section below. Every terpene — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — is covered with preclinical and review-level evidence.

The formulas published in this document are anchored to per-compound evidence summaries that explain what is well-supported by human clinical data, what is emerging, and what is overstated. We do not exempt ourselves from the same evidence standards we apply to the broader cannabinoid field. That is intentional.

As Colin Valencia said in 2019, people deserve the best possible version of the information so they can give it a fair shot and decide for themselves whether it is right or wrong for them. This document is the research foundation for that position.

OilWell Cannabis is more than a brand — it is a promise to our customers that we will always strive to deliver the best, most thoughtful cannabis products available. We are not here to follow trends. We are here to set them. And as we continue to grow, our focus remains on maintaining the same level of integrity, creativity, and commitment that has defined us from the day Bentley got up, walked across the room, and brought his ball to play.

MEDIA RECOGNITION AND COMMUNITY IMPACT

Colin Valencia — Houston’s go-to cannabis authority (and what it means for Haralson County)

Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different ABC13 reporters sought Colin out across those years. No other Houston cannabis operator appears with that frequency or across that breadth of subject matter.

Why does this matter for Haralson County? Because mainstream media validation from a major-market ABC affiliate establishes credibility that transcends geography. When you’re considering a cannabis product in Buchanan or Bremen, you want to know you’re dealing with a company that major news organizations trust as an expert source — not a fly-by-night operation.

The features document a consistent pattern. When ABC13 needed to explain a new cannabis product, it called Colin. When a state agency reversed course on Delta-8 legality overnight, it called Colin. When a sitting president announced marijuana pardons and the station needed someone who had personally lived with a cannabis conviction to put it in context, it called Colin.

Featured segments summary

September 15, 2019 — Texas CBD businesses booming
Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

March 22, 2021 — Decriminalization efforts
Colin’s therapy quote: “Pain comes in a lot of different forms.” This resonates across Haralson County, where pain from manual labor, aging, and service-related injuries affects many families.

May 24, 2021 — Delta-8 THC investigation
Colin’s iconic honesty: “Maybe you want to get high.” Radical transparency on mainstream television.

August 20, 2021 — COVID vaccine giveaway
OilWell gave away 1,000 caviar pre-rolls (approximately $35,000 in product) to encourage vaccination, coordinating with the city of Houston. This demonstrates community commitment that transcends profit.

October 19, 2021 — Delta-8 ban impact
When Texas classified Delta-8 as Schedule I overnight, Colin proactively removed all products before enforcement and warned other operators who were unknowingly shipping Schedule I narcotics. This ethical leadership during crisis demonstrates character.

October 7, 2022 — Biden marijuana pardon
Colin revealed his personal marijuana conviction history: “You face challenges with housing, loans, and banking, I mean with about everything.” He also said: “I would love to see people not get hurt for this anymore.” This personal stake transforms every quote and makes the company’s mission more authentic.

April 21, 2023 — Texas marijuana laws
Colin’s “Renaissance” framing: “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”

The through-line

These seven features over four years reveal consistent themes:

• Consistency across years — The same honest approach, repeated in every interview
• Breadth of expertise — From business to medicine to law to community health
• Community action — $35,000 vaccine giveaway, proactive Delta-8 removal
• Personal stakes — Lived experience with cannabis conviction and PTSD
• Evolution — Growing from local wholesaler to industry authority

For Haralson County residents, this media record means you’re dealing with a company that has earned recognition through integrity, not purchased it through marketing.

GENERAL KNOWLEDGE

Research method and evidence weighting

This section prioritizes sources in the following order: human clinical evidence, systematic reviews and meta-analyses, NIH and other institutional summaries, then mechanistic or preclinical literature when human data are sparse. That weighting matters because the evidence base is not evenly distributed. Of the compounds in our formula, CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes are still much more dependent on reviews, animal work, in vitro pharmacology, or early translational literature [1]-[29].

Institutional baseline from NIH and related sources

• The National Center for Complementary and Integrative Health (NCCIH) states that the strongest established cannabinoid evidence is for certain rare epilepsies, chemotherapy-related nausea and vomiting, and appetite or weight-loss indications associated with HIV/AIDS. It notes only modest evidence for chronic pain and multiple-sclerosis-related symptoms, with many other claimed uses still in early-stage research [1].
• The FDA has not approved the cannabis plant itself for medical use, although purified CBD and synthetic THC-like drugs have specific approvals [1].
• Safety concerns highlighted by NIH include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy-related concerns, accidental pediatric exposure, contamination or labeling inaccuracy, and THC-vape lung-injury concerns [1].
• NCCIH warns that over-the-counter CBD products may differ from their labels and that CBD itself has been associated with decreased alertness, gastrointestinal effects, liver-related adverse effects, and drug interactions [1].

Cannabinoids

CBD (Cannabidiol)

• Evidence profile: Strongest human evidence in our formula, especially as purified product [1]-[6].
• Best supported: Purified CBD has the most credible human evidence in seizure disorders [1][2].
• Anxiety: A 2024 systematic review and meta-analysis covering 316 participants across eight articles reported a statistically significant anxiolytic signal, but authors stressed the clinical sample remains limited and more trials are needed [3].
• Pain: A 2024 systematic review concluded the pain literature is promising but heterogeneous, with trial quality and consistency still limiting confidence in broad analgesic claims [4].
• Sleep: A 2023 insomnia review found the literature remains methodologically weak, with few objective sleep assessments [5].
• Safety: A 2023 systematic review and meta-analysis found a real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH flags diarrhea, sleepiness, appetite change, mood effects, liver-function abnormalities, and drug-drug interactions [1].
• Bottom line: CBD is the most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in specific indications rather than broad wellness claims [1]-[6].

CBG (Cannabigerol)

• Evidence profile: Mostly review-level and preclinical; human evidence remains sparse [7][8].
• Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids with interactions spanning cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling [7].
• Potential areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses [7][8].
• Caution: A 2021 review notes CBG is already being sold commercially while the evidence base remains thin [7].
• Bottom line: CBG is a promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC

• Evidence profile: Pharmacologically relevant, psychoactive, and much less clinically characterized than delta-9 THC [9]-[11].
• Comparative pharmacology: A 2022 review concluded delta-8 THC and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 THC is a partial CB1 agonist with cannabimimetic activity, appearing less potent than delta-9 THC [9].
• Public-health literature: A 2023 scoping review found the delta-8 evidence base dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong modern human trials [10].
• Manufacturing context: A 2024 review notes commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, with product-byproduct and lab-testing questions [11].
• Bottom line: Delta-8 THC should be treated as a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and manufacturing-quality uncertainty [9]-[11].

THCa (Tetrahydrocannabinolic Acid)

• Evidence profile: Important chemically and formulation-wise, but still low on direct human therapeutic evidence [12].
• What it is: THCa is the acidic precursor of THC and may represent a large share of THC-related content in raw plant material. It decarboxylates into THC during heating and can change over time during storage and processing [12].
• Psychoactivity: THCa itself does not produce psychoactive effects, but the distinction only holds if the molecule stays in its acidic form and is not substantially decarboxylated [12].
• Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not established human outcomes [12].
• Bottom line: THCa is best understood as a highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage [12].

Delta-9 THC

• Evidence profile: Strongest human evidence of the psychoactive cannabinoids, but also the clearest adverse-effect burden [1][13]-[15].
• Institutional support: NCCIH identifies THC-containing medicines as relevant to chemotherapy-related nausea and vomiting, appetite and weight loss in HIV/AIDS, and some multiple-sclerosis- and pain-related outcomes [1].
• Pain evidence: A 2022 systematic review found products with high THC content or comparable THC:CBD ratios may provide short-term pain benefit but increased dizziness, sedation, nausea, and treatment discontinuation [13].
• Pharmacokinetics: Inhaled THC produces effects within seconds to minutes, peaking in 15-30 minutes; oral THC has later onset, later peak, and longer duration [14].
• Mental-health risk: A 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis or schizophrenia outcomes and cannabis use disorder, with concerning signals for anxiety and depression [15].
• Broader safety: Literature describes anxiety or panic at high doses, tachycardia, blood-pressure changes, dependency potential, withdrawal symptoms, pregnancy concerns, accidental pediatric exposure, and vape-related lung-injury concerns [1][14][15].
• Bottom line: Delta-9 THC has legitimate therapeutic relevance but carries the clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN (Cannabinol)

• Evidence profile: Weak human evidence; marketing has moved ahead of the data [12][16][17].
• What it’s marketed for: Sleep and sedation, but clinical support is far thinner than the market suggests [16][17].
• Sleep research: A 2021 narrative review screened 99 human-study abstracts, reviewed eight full-text articles, and found no clinical trials using validated sleep questionnaires or formal polysomnography [16].
• Broader sleep literature: A 2024 updated review concluded overall cannabinoid sleep research still does not match real-world use scale [17].
• Chemical context: THCa can degrade toward CBN under certain conditions [12].
• Bottom line: CBN is one of the clearest examples where cultural reputation is stronger than current clinical evidence [16][17].

CBC (Cannabichromene)

• Evidence profile: Emerging, intriguing, and still overwhelmingly preclinical or review-based [18][19].
• Pharmacology: A 2024 focused review argues CBC has distinct pharmacodynamics, pharmacokinetics, and receptor behavior, highlighting antinociceptive, antibacterial, and anti-seizure areas as research targets [18].
• Older literature: Review literature reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological relevance, but these are not strong evidence for patient-facing claims [19].
• Safety caveat: The 2024 CBC review notes over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom line: CBC belongs in the category of scientifically credible minor cannabinoids deserving more research, not already-validated clinical actives [18][19].

Terpenes

Terpenes need even stricter interpretation than cannabinoids. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. The 2024 entourage-effect review makes this especially important: terpene bioactivity is plausible, but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence profile: Largely review and preclinical, with useful safety literature [20]-[22].
• Potential activity: A 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities, mostly from nonhuman literature [21].
• Safety note: Limonene oxidation products are clinically relevant contact allergens [22].
• Bottom line: Limonene is biologically active, but cannabis-specific therapeutic claims should stay conservative [20]-[22].

Myrcene

• Evidence profile: Mostly preclinical, very limited human evidence [20][23].
• Research summary: A 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, explicitly stating human studies are lacking [23].
• Interpretation caution: Claims that myrcene reliably causes sedation remain ahead of human evidence [20][23].
• Bottom line: Myrcene is plausible but compound-specific clinical claims remain far ahead of definitive proof [23].

Caryophyllene

• Evidence profile: Among the most mechanistically interesting due to direct CB2 receptor agonism, but still mostly preclinical [24].
• Why it stands out: A 2021 focused review describes beta-caryophyllene as a selective CB2 receptor agonist, unusual and relevant for pharmacologic discussion [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions discussed, but human clinical confirmation remains limited [24].
• Bottom line: Beta-caryophyllene is arguably the strongest candidate for a terpene with cannabinoid-system significance, but still not clinically proven for most outcomes [24].

Pinene

• Evidence profile: Promising preclinical literature, weak human clinical confirmation [20][25].
• Brain-health framing: A 2021 review found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized well-designed clinical trials are lacking [25].
• Interpretation caution: Claims that pinene reliably improves memory or counterbalances THC cognitive effects remain exploratory hypotheses [20][25].
• Bottom line: Pinene deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool

• Evidence profile: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].
• Research summary: Discussed in relation to stress, mood, brain-health pharmacology. A 2021 review found enough preclinical signal to justify continued investigation [25].
• Additional literature: Separate reviews discuss possible antidepressant mechanisms, but this remains translational rather than definitive [26].
• Safety note: Oxidized linalool hydroperoxides are recognized allergens [22].
• Bottom line: Linalool is scientifically credible but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene

• Evidence profile: Translationally interesting but early [20][27].
• Scoping-review findings: A 2024 scoping review analyzing 340 articles found broad preclinical evidence, with some rodent work suggesting cannabimimetic properties [27].
• Interpretation caution: Findings are valuable for hypothesis generation but do not establish consistent human efficacy [27].
• Bottom line: Humulene is an interesting research target but remains far from clinically settled [27].

Terpinolene

• Evidence profile: One of the least clinically characterized terpenes [20][28].
• Systematic-review findings: A 2021 review screening 2,449 records concluded the evidence base is dominated by in silico, in vitro, and animal studies [28].
• Bottom line: Terpinolene is biologically interesting but especially underdeveloped clinically [20][28].

Research limits and interpretation

• The evidence base is highly uneven. CBD and delta-9 THC support the most detailed human-facing statements; the rest require more caution [1]-[29].
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable.
• Minor cannabinoids and terpenes are commercially interesting because they’re underexplored, but claims often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, and dose variability affect interpretation [1][10][11][14].
• For THCa, chemistry is destiny: storage and heating can change exposure profiles by converting acidic cannabinoids into neutral cannabinoids like THC [12].

Common overstatements to avoid

• Overstatement: CBN is a clinically proven sleep cannabinoid.
  More accurate: Sleep evidence for CBN remains weak, with no strong validated-trial base [16][17].
• Overstatement: Myrcene is a proven human sedative that reliably causes couch-lock.
  More accurate: Myrcene has preclinical bioactivity, but direct human proof is limited [20][23].
• Overstatement: Terpenes have proven entourage effects in patients.
  More accurate: Entourage hypotheses are influential but robust clinical proof remains limited [20][29].
• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating converts THCa into THC [12].
• Overstatement: Delta-8 THC is safe because it’s hemp-derived.
  More accurate: Delta-8 THC is psychoactive with incomplete safety characterization [9]-[11].

Practical takeaways for Haralson County residents

• The most evidence-developed actives are CBD and delta-9 THC.
• Delta-8 THC is not trivial; it’s a psychoactive cannabinoid with less robust safety characterization than delta-9 THC.
• THCa meaningfully changes with processing and should not be interpreted the same way in raw vs. heated formats.
• CBG, CBN, and CBC are scientifically credible but clinically immature compared with CBD and THC.
• The terpenes are likely relevant to aroma, flavor, and potentially some bioactivity, but compound-specific human therapeutic claims should be made carefully and only where directly supported.

RSO SUBLINGUAL OIL FORMULA

Complete open-source formula (Georgia residents can make this themselves if they choose):

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle
• Active cannabinoids per mL: 553mg
• Base: Organic MCT oil
• Price: $129.99

This formula is simultaneously a product specification, an educational tool, and a recipe for DIY makers in Haralson County who may want to source individual cannabinoids and create their own version. Every number connects back to a compound in the GENERAL KNOWLEDGE section with its own evidence profile.

RSO VAPE CARTRIDGE FORMULA

Complete open-source formula:

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• Compatibility: 510-thread universal battery
• Price: $49.99

The vape format vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids — the fastest-onset RSO delivery method available for breakthrough symptoms.

TERPENE PROFILE (BOTH PRODUCTS)

• Limonene — citrus-bright aroma
• Myrcene — earthy, musky notes
• Caryophyllene (β-caryophyllene) — pepper/spice character
• Pinene — forest-fresh scent
• Linalool — floral, lavender notes
• Humulene — earthy, woody aroma
• Terpinolene — piney, fruity, sparkling complexity

This seven-terpene profile is consistent across both product formats and was specifically designed to complement the cannabinoid formula. The sensory experience — from the citrus brightness of limonene to the forest-fresh pinene notes — makes the product experience enjoyable while the science suggests potential synergistic effects through the entourage effect.

For Haralson County residents seeking more information, to place an order, or to request Certificates of Analysis:

OilWell Cannabis

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/
• Address: 810 Richmond Ave, Houston, TX 77006
• Instagram: @oilwellcbd

We ship directly to Haralson County, Georgia, with discreet packaging and full legal documentation. All products are Farm Bill compliant, third-party lab tested, and backed by our commitment to honest education over hype.

Age requirement: 21+ for all RSO products.

FDA disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before use.

Safety warning: May cause drowsiness or impairment. Do not operate vehicles or machinery while under the influence. Keep out of reach of children. If pregnant or nursing, consult a physician before use.

Legal responsibility: Buyer assumes responsibility for checking local laws. We assume no legal responsibility for customer’s use or decarboxylation decisions. Void where prohibited by law.